AB Science provides the summary of webcast with Key Opinion Leaders on masitinib Phase 3 results in severe asthma uncontrolled by oral corticosteroids

    NEXT STORY
    Femtech Market value to cross $48.5 billion by 2025: Global Market Insights, Inc.
    PREV STORY
    Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Teneobio Announces Research Collaboration with Janssen to Develop Multispecific Antibodies for Oncology 

    MENLO PARK, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Teneobio, Inc., a next generation ...

    author_avatar
    NASDAQ Market News

    Zai Lab Appoints Industry Leader Tao Fu as President & Chief Operating Officer, Expands US Presence

    Mr. Fu will oversee global business development, discovery, manufacturing and other operational activities in ...

    author_avatar
    NASDAQ Market News

    Ballad Health Reports Six-Month Results: Better Quality, Strong Financial Performance, and Significant Capital Investments

    author_avatar
    NASDAQ Market News